drugset / Trial / NCT02349165
Standard Versus Transepithelial Corneal Crosslinking
Completed
61 enrolled
Nienke Soeters
Dr. F.P. Fischer Stichting · collabStichting Nederlands Oogheelkundig Onderzoek · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The gold standard corneal crosslinking (CXL) technique involves the initial step of epithelial removal, in order to achieve a sufficient treatment effect (meaning: stabilisation of progressive keratoconus (KC). Our aim is to evaluate the effects of transepithelial CXL (TE-CXL), whereby the epithelium is left intact and the cornea is instead treated by a solution composed of 0.1% riboflavin, combined with enhancers, after which standard CXL is performed. This solution seems to facilitate riboflavin penetration into the corneal stroma through the intact epithelium. The investigators expect to achieve a similar effect of TE-CXL with the advantage of a faster healing time and less risk of infections.
Timeline
- Start
- 2011-05
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Isotonic riboflavin | Unknown | — | Other |
| Subject | Ricrolin TE | Unknown | — | Other |